Overview

A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients

Status:
Enrolling by invitation
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
A Multicenter, Comparative Safety and Efficacy Study of Acthar gel alone or in combination with oral Tacrolimus to reduce urinary proteinuria in patients with idiopathic DNAJB9 Positive Fibrillary glomerulopathy.
Phase:
Phase 4
Details
Lead Sponsor:
NephroNet, Inc.
Collaborator:
Mallinckrodt
Treatments:
Tacrolimus